Quant Aggressive Hybrid Fund
Direct Plan · IDCW Option · quant Mutual Fund
Returns
Annualised (CAGR) returns for periods over a year.
Want to invest in this fund?
Open a free demat & trading account with Zerodha to invest in direct mutual funds with zero commission.
Rank in Category
| Period | This Fund | Category Avg. | Rank |
|---|---|---|---|
| 1W | +4.37% | +3.49% | 1 of 30 |
| 1M | +2.63% | +2.55% | 21 of 30 |
| 3M | -3.17% | -2.60% | 22 of 30 |
| 6M | +3.24% | +0.93% | 8 of 29 |
| YTD | +5.54% | -2.60% | 3 of 30 |
| 1Y | +6.56% | -2.48% | 3 of 29 |
| 2Y | +6.10% | +0.81% | 6 of 29 |
| 3Y | +14.04% | +8.88% | 3 of 29 |
| 5Y | +12.18% | +7.07% | 4 of 26 |
| 7Y | +19.44% | +10.70% | 2 of 25 |
| 10Y | +14.54% | +8.21% | 2 of 19 |
| INCEPTION | +13.69% | — | — |
Ranked among: Hybrid Scheme - Aggressive Hybrid Fund.
Rolling Returns
| Period | Average | Best | Worst | Positive Periods | Consistency |
|---|---|---|---|---|---|
| 3M | +3.94% | +32.49% | -26.29% | 67% | 26% |
| 6M | +8.13% | +53.29% | -24.74% | 70% | 28% |
| 1Y | +17.33% | +105.97% | -22.58% | 81% | 34% |
| 2Y | +15.32% | +64.65% | -8.18% | 89% | 39% |
| 3Y | +15.05% | +41.87% | -4.87% | 96% | 42% |
| 5Y | +15.24% | +31.80% | -3.71% | 98% | 44% |
| 7Y | +15.21% | +21.73% | +5.09% | 100% | 45% |
| 10Y | +14.56% | +17.52% | +11.20% | 100% | 46% |
Rolling returns show the average, best and worst outcome an investor would have seen entering at any point in the window.
NAV History
AUM Trend (₹ Cr, quarterly average)
Expense Ratio Trend
Portfolio · Sep 2026
Asset Allocation
- Equity69.92%
- Debt21.24%
- Cash8.62%
- Other0.22%
Market Cap Split
- Large Cap50.30%
- Mid Cap17.65%
- Small Cap1.97%
- Others30.08%
Fundamentals
| Fund | Category | |
|---|---|---|
| P/E | 25.39 | 24.21 |
| P/B | 3.75 | 3.45 |
| Price / Sales | 2.41 | 3.16 |
| Price / Cash Flow | 18.47 | 17.54 |
| Dividend Yield (%) | 2.08 | 1.31 |
Holdings · Sep 2026
| Holding | Sector | Weight | Change (1M) |
|---|---|---|---|
| Zydus Life Science | Pharmaceuticals & Biotechnology | 9.62% | +5.99% |
| Adani Enterprises | Metals & Minerals Trading | 9.30% | +0.36% |
| TREPS 01-Oct-2026 DEPO 10 | N.A. | 8.55% | — |
| Adani Green Energy | Power | 8.25% | +0.59% |
| Aurobindo Pharma | Pharmaceuticals & Biotechnology | 8.03% | -0.02% |
| Divis Laboratories | Pharmaceuticals & Biotechnology | 7.80% | — |
| Adani Power | Power | 6.68% | +0.35% |
| LIC of India | Insurance | 5.94% | -0.20% |
| SIDBI CD 10-Nov-2026 | Money Market | 4.71% | +0.13% |
| 364TB19227 | SOV | 4.64% | +0.13% |
| Reliance Industries | Petroleum Products | 4.54% | -0.23% |
| Bharat Heavy Electricals | Electrical Equipment | 3.82% | -0.16% |
| Reliance Industries | Petroleum Products | 3.74% | -1.03% |
| Infosys | IT - Software | 2.42% | -0.27% |
| 182T191126 | SOV | 2.36% | +0.07% |
View all 30 holdings
| 723MHSDL35 | SOV | 2.29% | +0.03% |
| GOI LOAN 6.79% 2034 | SOV | 1.62% | +0.01% |
| LTM | IT - Software | 1.55% | -0.15% |
| IRB InvIT Fund | Transport Infrastructure | 1.45% | — |
| 9% Capri Global Capital Ltd 30Apr2028 | Debt | 1.18% | +0.03% |
| 91TB241226 | SOV | 1.17% | — |
| 726GOI2033 | SOV | 0.96% | +0.01% |
| 664GOI35 | SOV | 0.84% | +0.01% |
| GS12MAR28C | SOV | 0.80% | +0.02% |
| Raajmarg Infra Investment Trust | Transport Infrastructure | 0.52% | +0.01% |
| GOI LOAN 7.29% 2033 | SOV | 0.48% | +0.00% |
| QUANT GILT FUND -DIRECT PLAN-GROWTH | N.A. | 0.30% | +0.01% |
| 574GS2026 | SOV | 0.19% | +0.00% |
| NCA-NET CURRENT ASSETS | N.A. | 0.07% | — |
| Bharat Heavy Electricals | Electrical Equipment | -3.82% | -7.80% |
Sector Allocation · Sep 2026
Risk Metrics
Standard Deviation
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 13.49 | 11.50 | High Volatility |
| 3Y | 13.11 | 11.26 | High Volatility |
| 5Y | 13.38 | 11.20 | High Volatility |
What is this?
Annualized population standard deviation of daily denomination-adjusted NAV returns, multiplied by sqrt(252). Values require a full timeframe of NAV history.
Sharpe Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | -0.03 | -0.78 | Above Average |
| 3Y | 0.56 | 0.17 | Above Average |
| 5Y | 0.51 | 0.13 | Above Average |
What is this?
Annualized Sharpe ratio calculated from month-end NAV returns using the latest available FBIL Overnight MIBOR rate as the risk-free rate. For schemes with less than three years of history, the 3Y value uses since-inception data. Applied risk-free rate: 5.73% (published 2026-10-28).
Sortino Ratio
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 0.77 | -0.24 | Above Average |
| 3Y | 1.55 | 1.15 | Above Average |
| 5Y | 1.31 | 0.94 | Above Average |
What is this?
Annualized from daily NAV returns using a 0.00% minimum acceptable return; downside deviation includes only returns below this target.
Beta
| Period | Fund | Category | |
|---|---|---|---|
| 1Y | 1.33 | 1.13 | Poor Risk Adjusted Returns |
| 3Y | 1.30 | 1.12 | Poor Risk Adjusted Returns |
| 5Y | 1.26 | 1.09 | Poor Risk Adjusted Returns |
What is this?
This value gives idea about how volatile fund performance has been compared to similar funds in the market. Lower beta implies the fund gives more predictable performance compared to similar funds in the market.
Compare With Peers
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
BANK OF INDIA AGGRESSIVE HYBRID FUND
Direct Plan · Growth
|
+10.31% | +15.80% | +14.07% | +15.94% |
|
Navi Aggressive Hybrid Fund
Regular Plan · Growth
|
+5.40% | +10.82% | +8.88% | +9.76% |
|
Bandhan Aggressive Hybrid Fund
Regular Plan · Growth
|
+3.77% | +13.75% | +9.99% | +10.97% |
|
HSBC Aggressive Hybrid Fund
Regular Plan · Growth
|
+2.40% | +12.35% | — | +12.24% |
|
Mirae Asset Aggressive Hybrid Fund
Direct Plan · Growth
|
+1.83% | +12.04% | +9.58% | +12.94% |
|
SBI AGGRESSIVE HYBRID FUND
Regular Plan · IDCW
|
+1.05% | +11.90% | +8.80% | +5.19% |
|
Shriram Aggressive Hybrid Fund
Direct Plan · Growth
|
-0.24% | +9.51% | +8.02% | +10.64% |
|
Edelweiss Aggressive Hybrid Fund
Plan B · Growth
|
-0.27% | +11.67% | +11.17% | +11.47% |
|
Kotak Aggressive Hybrid Fund
Regular Plan · Payout of Income Distribution cum capital withdrawal option- Direct
|
-0.27% | +11.66% | +9.84% | +2.27% |
|
Canara Robeco Aggressive Hybrid Fund
Regular Plan · GROWTH OPTION
|
-0.82% | +10.29% | +7.97% | +11.90% |
More From quant Money Managers Limited
| Scheme | 1Y | 3Y | 5Y | Since Inception |
|---|---|---|---|---|
|
quant Healthcare Fund
Direct Plan · Growth Option
|
+17.80% | +21.17% | — | +21.00% |
|
quant ESG Integration Strategy Fund
Direct Plan · Growth Option
|
+16.86% | +17.50% | +17.46% | +26.83% |
|
quant Manufacturing Fund
Direct Plan · Growth Option
|
+8.86% | +15.28% | — | +17.09% |
|
Quant Multi Asset Allocation Fund
Direct Plan · Growth Option
|
+8.85% | +21.07% | +18.00% | +15.43% |
|
Quant Small Cap Fund
Direct Plan · Growth Option
|
+8.79% | +17.03% | +17.20% | +17.27% |
|
Quant Value Fund
Direct Plan · Growth Option
|
+8.77% | +19.60% | — | +18.36% |
|
Quant Large & Mid Cap Fund
Direct Plan · Growth Option
|
+8.49% | +15.61% | +15.06% | +17.68% |
|
Quant Flexi Cap Fund
Direct Plan · Growth Option
|
+8.47% | +15.75% | +14.18% | +18.14% |
|
Quant ELSS Tax Saver Fund
Direct Plan · Growth Option
|
+8.35% | +15.24% | +14.23% | +19.51% |
|
quant Equity Savings Fund
Direct Plan · Growth Option
|
+8.02% | — | — | +8.08% |
About This Scheme
Investment Objective
The investment objective of the scheme is to generate income/capital appreciation by investing primarily in equity and equity related instruments with a moderate exposure to debt securities & money market instruments. There is no assurance that the investment objective of the Scheme will be achieved.
Stated Asset Allocation
Equity and equity related instruments(including units issued by REITs):- 65-80% Debt and money market instruments:- 20-35% Units issued by InvITS:- 0-10%
Exit Load
For redemptions / switch outs (including SIP/STP) within 15 days from the date of allotment of units, irrespective of the amount of investment: 1% No exit load shall be applicable on switches from Regular Plan to Direct Plan and vice versa, under the same scheme
Mutual fund investments are subject to market risks. Read all scheme related documents carefully. Past performance is not indicative of future returns. Data is sourced from AMFI and fund houses via FinAPI and may lag official figures.
GMP IPO Watch